With over two decades of experience in publishing in vitro diagnostic (IVD) market research, Kalorama Information presents the 30 Country In Vitro Diagnostics (IVD) Market Atlas, 2024. This quarterly updated report offers a unique approach focused on country-level research and analysis, providing a detailed analysis of major IVD segments forecasted for five years across 30 countries. (In Vitro Diagnostic Markets for US, China, Germany, UK, Saudi Arabia, India, UAE, France, Vietnam, Turkey and 20 Other Countries)
What’s Included:
- One report covering 30 countries
- Sizing for 20 important IVD market segments
- Segments estimated for each country
- Forecasts to 2028 for each segment
- Updated quarterly (4 updates annually) to reflect market changes
- Over 2800 data points
Key Features:
- Detailed analysis of major IVD segments
- Coverage of 30 countries including Australia, Brazil, China, Germany, India, Japan, United States, and more
- Global market estimates and breakdowns for each country
- Comprehensive and timely information in one report
Market Segments Covered:
- General Chemistries
- Critical Care (core lab)
- Hematology
- Coagulation PT/Routine
- Immunoassays – Micro
- Immunoassays – Non-Micro
- Blood Bank Screening – Immunos
- Microbiology – ID/AST
- Molecular Respiratory
- Molecular Bloodstream/HAI
- Molecular HIV & Hepatitis
- Molecular – Other¹
- POC Glucose (all)
- POC Critical Care
- POC Infectious Disease (all)
- POC Pregnancy & Fertility
- POC Fecal Occult
- Other POC
- Histology
- Other IVD
Updated Quarterly: The report is updated every quarter throughout 2024 to reflect market changes, ensuring that subscribers have the most up-to-date data for their business planning.
Subscription Benefits: Subscribers will receive quarterly updates through Kalorama Information’s Knowledge Center product, providing continuous access to the latest market insights and trends in the IVD market.
For further details and to purchase directly, please contact us.
Sample Report: A sample is available as a PDF upon request.
Table: India IVD Market, by Segment, Estimated 2023-2028 (in millions $)
| Segment | 2023 | 2028 | CAGR |
| General Chemistries | $XX Million | $XX Million | XX% |
| Critical Care (core lab) | $XX Million | $XX Million | XX% |
| Hematology | $XX Million | $XX Million | XX% |
| Coagulation PT/Routine | $XX Million | $XX Million | XX% |
| Immunoassays – Micro | $XX Million | $XX Million | XX% |
| Immunoassays – Non-Micro | $XX Million | $XX Million | XX% |
| Blood Bank Screening – Immunos | $XX Million | $XX Million | XX% |
| Microbiology – ID/AST | $XX Million | $XX Million | XX% |
| Molecular Respiratory | $XX Million | $XX Million | XX% |
| Molecular Bloodstream/HAI | $XX Million | $XX Million | XX% |
| Molecular HIV & Hepatitis | $XX Million | $XX Million | XX% |
| Molecular – Other (blood screening, STDs, and other microbiology) | $XX Million | $XX Million | XX% |
| POC Glucose (all) | $XX Million | $XX Million | XX% |
| POC Critical Care | $XX Million | $XX Million | XX% |
| POC Infectious Disease (all) | $XX Million | $XX Million | XX% |
| POC Pregnancy & Fertility | $XX Million | $XX Million | XX% |
| POC Fecal Occult | $XX Million | $XX Million | XX% |
| Other POC | $XX Million | $XX Million | XX% |
| Histology | $XX Million | $XX Million | XX% |
| Other IVD | $XX Million | $XX Million | XX% |
| Total India IVD Market | $XX Million | $XX Million | XX% |
Note: Updated March 2024
